Clinical trials
Hematologic Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 2 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 9 |
| 2022 | 7 |
| 2023 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Active, not recruiting | 14 |
| Terminated | 6 |
| Recruiting | 5 |
| Enrolling by invitation | 2 |
| Unknown status | 2 |
| No longer available | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| BioMarin Pharmaceutical | 5 |
| Loxo Oncology, Inc. | 5 |
| Seagen Inc. | 5 |
| Vertex Pharmaceuticals Incorporated | 5 |
| Pfizer | 4 |
| Takeda | 4 |
| Swedish Orphan Biovitrum | 3 |
| Abbott Medical Devices | 2 |
| Baxalta now part of Shire | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 70 |
| Hemorrhagic Disorders | 17 |
| Genetic Diseases, Inborn | 16 |
| Blood Coagulation Disorders | 15 |
| Hemophilia A | 13 |
| Bone Marrow Diseases | 12 |
| Coagulation Protein Disorders | 12 |
| Leukemia | 12 |
| Lymphoma | 10 |
| Lymphoma, Non-Hodgkin | 10 |
Trials
Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.